Skip to content

Project to Improve the Diagnosis and Treatment Ability of Adult Severe Community Acquired Lower Respiratory Tract Infection

Project to Improve the Diagnosis and Treatment Ability of Adult Severe Community Acquired Lower Respiratory Tract Infection

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04959955
Enrollment
200
Registered
2021-07-13
Start date
2015-08-08
Completion date
2019-12-12
Last updated
2021-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CAP, COPD Exacerbation

Brief summary

1. Objective to understand the proportion of atypical pathogens in the pathogens of SCAP and AECOPD in urban hospitals in China. 2. Objective to investigate the antimicrobial resistance of atypical pathogens in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) and SCAP in urban hospitals. 3. Objective to master the important clinical characteristics of patients with acute exacerbation of SCAP and COPD caused by atypical pathogens and mixed infection in urban hospitals in China, and to put forward the experience judgment index. 4. Objective to evaluate the advantages of various diagnostic methods for atypical pathogens causing lower respiratory tract infection. 5. It is suggested that the current empirical treatment of SCAP and severe COPD in China should be improved.

Interventions

None listed

Sponsors

First Hospital of China Medical University
CollaboratorOTHER
Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* SCAP * AECOPD

Exclusion criteria

* Pregnant or lactating women. * Patients with bronchiectasis. * Patients with active pulmonary tuberculosis. * Aspiration pneumonia or obstructive pneumonia. * Two weeks before the onset of hospital treatment history, this infection can not be excluded from hospital acquired infection. * HIV positive patients (but HIV testing is not required). * Patients who are unable and / or unable to understand and / or implement the investigation protocol.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of atypical pathogens and mixed infections2year IncidenceIncidence of atypical pathogens and mixed infections

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026